Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients. (Q48663035)
Jump to navigation
Jump to search
scientific article published on 10 July 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients. |
scientific article published on 10 July 2014 |
Statements
Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients (English)
Peter Dubsky
Christoph C Zielinski
Guenther G Steger
Rupert Bartsch
Zsuzsanna Bago-Horvath
Gerda Ricken
Margareta Rudas
Berthold Streubel